MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function
about
A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcriptionHoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalizationMolecular basis of p53 functional inactivation by the leukemic protein MLL-ELLRedox regulation of FoxO transcription factorsStructures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitmentIdentification and analysis of evolutionary selection pressures acting at the molecular level in five forkhead subfamilies.The FOX transcription factors regulate vascular pathology, diabetes and TregsSelf-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-κB and transcription regulatory factors.Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes.The many forks in FOXO's road.Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway.MLL fusions: pathways to leukemiaInduction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expressionTransformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potentialMeis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.In control of biology: of mice, men and FoxesRas as a therapeutic target in hematologic malignancies.Review: genetic models of acute myeloid leukaemia.miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathwaysBinding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1.Molecular mechanisms of MLL-associated leukemia.FOXO transcription factors in cancer development and therapy.Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.Protein arginine-methyltransferase-dependent oncogenesis.Transcriptional activation is a key function encoded by MLL fusion partners.Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.FOXO in Neural Cells and Diseases of the Nervous System.The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
P2860
Q24299122-F318B8A7-FA2B-4407-9EE6-2B44132C0E86Q24603527-F3E9CD17-3B7E-4DCA-8283-1A13902B338BQ24675588-50943D8C-E08B-47DF-88F5-5974BBD7EEA2Q26799843-BFEED19B-19AC-4C9A-8EC9-A6578C9781A0Q27678321-9DE8D529-FB64-4B93-8DD9-58512C7B0848Q33371818-D72A2AAD-5993-4BE4-8590-0BC1EC34D53EQ33763033-8DA9BCC7-E7B9-45F7-B5B8-8945B4ED7C68Q33997220-EA522CB2-6BB6-4A4E-9FF7-AB61F5C611D7Q34035076-001DCEC7-8F50-43E9-89C3-F2486846DE89Q34210060-F45E8320-AD55-4653-AA7A-F31E36C3BE05Q34553972-ED215AC7-AFC7-4A87-BAC1-9E126DFB1594Q34581540-B8828E31-A612-4361-9A0A-CFAB6FE9CC97Q35079447-33CEC970-5112-477E-9CC6-2A9CB4FB7AD0Q35139549-9BF27B8A-34A3-4C2E-8DBB-CCFBFE42027CQ35586103-72AA69CC-95A4-4511-8090-3FBCEFD5BF22Q35788362-C80A7626-E8FA-4FC7-94B4-6B107355F58AQ35948212-4A393D1C-1002-48EA-BB8E-D11D058E9CEDQ35971222-403C75C5-65FE-40D1-8107-3365467D1142Q36010294-13AABFE1-976E-42F3-94D4-1C331F99871AQ36098242-0D5077C7-EFFA-4A4B-AB1B-22A1CCFCABF5Q36334327-41215130-3DDB-4A88-BB40-21315B12EDB1Q36508924-10D5B7F8-7A84-4465-89C7-4E094AFBF9F1Q36515335-80BBB89F-8AE0-437A-845E-A6A18DC1F396Q36866611-FE3254CC-2E84-492E-B014-6A15DB6BDCACQ37080843-3AA03E8F-7C6F-42E5-AD5E-C35068F65407Q37330835-6E355D6B-22A6-4B19-B3A7-F2377140267AQ37622891-C79E0D9F-7453-4C05-A8D5-B6A9B985EB3BQ38161393-1274DECC-0D96-46C1-9EC0-0A52A387CE4DQ38338516-C9839AE2-B731-4875-ADD4-BB13BD2885E0Q38379210-CFBED9B2-7CE6-48E6-AFEC-8261D2EA50BDQ38674456-28B90DBD-955D-4EE9-935E-6FD10006066FQ39000854-92E7764D-8EB3-4DAD-8CE8-EA25752C6B6CQ40077054-1E97460D-C220-4049-9145-7B1FCA316D21Q40669934-D3EC656A-F2DD-43DE-9C87-B5C8E710D181Q42176903-B54BCFC0-7FE6-434F-9B36-0247C2BEEDAAQ50057277-14F9C75C-3092-4AEC-963C-10727EB76174Q53607290-8D096D23-F532-48CC-8177-3B75683FC83F
P2860
MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
MLL-AFX requires the transcrip ...... with forkhead protein function
@ast
MLL-AFX requires the transcrip ...... with forkhead protein function
@en
MLL-AFX requires the transcrip ...... with forkhead protein function
@nl
type
label
MLL-AFX requires the transcrip ...... with forkhead protein function
@ast
MLL-AFX requires the transcrip ...... with forkhead protein function
@en
MLL-AFX requires the transcrip ...... with forkhead protein function
@nl
prefLabel
MLL-AFX requires the transcrip ...... with forkhead protein function
@ast
MLL-AFX requires the transcrip ...... with forkhead protein function
@en
MLL-AFX requires the transcrip ...... with forkhead protein function
@nl
P2860
P3181
P1476
MLL-AFX requires the transcrip ...... with forkhead protein function
@en
P2093
Chi Wai So
Michael L Cleary
P2860
P304
P3181
P356
10.1128/MCB.22.18.6542-6552.2002
P407
P577
2002-09-01T00:00:00Z